Ascentage Pharma Group International (AAPG) Accounts Payables (2023 - 2024)

Historic Accounts Payables for Ascentage Pharma Group International (AAPG) over the last 3 years, with Q2 2025 value amounting to $16.6 million.

  • Ascentage Pharma Group International's Accounts Payables changed N/A to $16.6 million in Q2 2025 from the same period last year, while for Jun 2025 it was $16.6 million, marking a year-over-year change of. This contributed to the annual value of $12.6 million for FY2024, which is 2290.34% up from last year.
  • Ascentage Pharma Group International's Accounts Payables amounted to $16.6 million in Q2 2025.
  • Ascentage Pharma Group International's Accounts Payables' 5-year high stood at $16.6 million during Q2 2025, with a 5-year trough of $10.1 million in Q4 2023.
  • For the 3-year period, Ascentage Pharma Group International's Accounts Payables averaged around $13.1 million, with its median value being $12.8 million (2024).
  • The largest annual percentage gain for Ascentage Pharma Group International's Accounts Payables in the last 5 years was 2724.6% (2024), contrasted with its biggest fall of 2724.6% (2024).
  • Quarter analysis of 3 years shows Ascentage Pharma Group International's Accounts Payables stood at $10.1 million in 2023, then grew by 27.25% to $12.8 million in 2024, then grew by 29.4% to $16.6 million in 2025.
  • Its last three reported values are $16.6 million in Q2 2025, $12.8 million for Q4 2024, and $10.1 million during Q4 2023.